Black CLL patients have shorter survival time despite equal treatment

07/8/2013 | U.S. News & World Report

Chronic lymphocytic leukemia appears to progress faster in black patients and to result in shorter survival times compared with white patients despite the administration of similar treatments. The study of 84 black patients and more than 1,500 nonblack patients took into account factors related to cancer severity and the timing of treatment. Researchers believe that, based on their results, biological factors may be involved in disparate outcomes. The study was reported in the journal Cancer.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ